Rigel Pharmaceuticals, Inc. Common Stock (NASDAQ: RIGL) last traded at $45.89, up 1.41% on the session. The quote above updates while this page is open; the figures below are drawn from Rigel Pharmaceuticals, Inc. Common Stock’s own filings and are restated only when a new one is published.
Rigel Pharmaceuticals, Inc. Common Stock trades on NASDAQ under the ticker RIGL. Its market capitalisation is $857.22 million.
Valuation measures for Rigel Pharmaceuticals, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $857.22M |
|---|---|
| Enterprise value | $892.05M |
| P/E ratio | 2.72 |
| Price / sales | 3.10 |
| Price / book | 2.01 |
| Beta | 0.77 |
Trailing-twelve-month figures tagged in Rigel Pharmaceuticals, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $276.79M |
|---|---|
| Net income (TTM) | $321.91M |
| EPS (TTM) | $16.89 |
| Operating margin | 31.45% |
| Return on equity | 75.67% |
| Cash | $60.82M |
Range and volume for RIGL over the past 52 weeks.
| 52-week high | $52.24 |
|---|---|
| 52-week low | $24.95 |
| Volume | 320.1K |
| Average volume | 358.4K |
| Previous close | $45.25 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.